Comprehensive Study Identifies a Sensitive, Low-Risk, Closed-System Model for Detection of Fungal Contaminants in Cell and Gene Therapy Products
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Microbiology"
DOI: 10.1128/jcm.01357-21
Abstract: The U.S. Food and Drug Administration (FDA) regulates manufacturing and testing of advanced therapeutic medicinal products (ATMPs) to ensure the safety of each product for human use. ABSTRACT The U.S. Food and Drug Administration (FDA)… read more here.
Keywords: fungal contaminants; test; product; detection fungal ... See more keywords